SAN DIEGO, June 9, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of Lewis Choi as Chief Information Officer, effective June...
PORTER RANCH, Calif., June 9, 2025 /PRNewswire/ -- Hydration Room, a doctor-founded leader in IV therapy and preventative wellness, has officially opened the doors...
Exhibits complex neurological processes—including memory, learning, and cognition—and predicts human outcomes in preclinical drug development
NEW ORLEANS, June 9, 2025 /PRNewswire/ -- 28bio today announced the Nexon™...
HANGZHOU, China, June 09, 2025 (GLOBE NEWSWIRE) -- On June 2, the 21st China International Cartoon & Animation Festival concluded in Hangzhou High-Tech Zone (Binjiang). The event showcased innovative scenarios where the animation industry merged with technology and daily services, offering a vivid glimpse into how the city elevates life through imaginative creativity and robust digital infrastructure.
CHENGDU, China, June 6, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", 6990.HK) today announced that results from its registrational study (OptiTROP-Lung03) evaluating...
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on June 2, 2025 (the “Grant Date”), ORIC granted a total of 39,100 non-qualified stock options and 6,500 restricted stock units to three new non-executive employees who began their employment with ORIC in May 2025.
OSLO, Norway, June 6, 2025 /PRNewswire/ -- Hemispherian AS, a pioneering biotech company developing next-generation therapeutics for aggressive cancers, announced today that the European...
Top three teams recognized for ideas to create sustainable electric mobility, tumor diagnostics accuracy and remote neurological monitoring
BENGALURU, India, and BLUE BELL, Pa.,...